Calamos Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Calamos Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-56,825	Closed	-$1.34M	–	1050
2023 Q4	$1.34M	Buy	+56,825	New	+$1.01M	0.01%	640

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Calamos Advisors's CBAY Position: Q1 2024 in Review

Calamos Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 56,825 shares — an estimated $1.34M sold.

Calamos Advisors first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $1.34M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Calamos Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Calamos Advisors sold 56,825 Cymabay Therapeutics shares in Q1 2024, an estimated $1.34M.
Calamos Advisors first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Calamos Advisors's Cymabay Therapeutics position peaked at $1.34M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Calamos Advisors's 13F filing for Q1 2024, filed 8 May 2024.